Animal Model Market to Reach USD 6.2 Billion by 2035, Driven by Biomedical Research and Rising Demand for Preclinical Studies

The global animal model industry was valued at US$ 2.5 Bn in 2024 and is projected to reach US$ 6.2 Bn by 2035, expanding at a CAGR of 8.6% from 2025 to 2035, driven by increasing demand for preclinical research, drug development, and biomedical studies.

The animal model industry is anticipated to witness steadiness throughout the forecast period. This could be attributed to the increasing demand for advanced scientific research in drug discovery and the use of preclinical trials. A growing number of investments in research and development activities, as well as government initiatives to support biomedical research, are likely to propel the market beyond the horizon. Further, it is estimated that the Asia-Pacific region will become a potential market with the highest rate of turnover, mainly due to the rapid development of healthcare infrastructure and favorable regulatory policies. This market is also complemented by innovations in genetic manipulation and the creation of more forecastable animal models.

Review significant findings and insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=73248

Market Overview

The animal model helps researchers to understand disease mechanisms, evaluate drug effectiveness, and measure the safety of new treatments before human application. Animal models have been relied on for the development of drugs, biotechnological innovation, and advancements in academic research over the past few decades due to their potential to simulate human physiological and pathological conditions.

The demand for better treatments is the main driver of the market, along with rising incidences of chronic and infectious diseases and the expanding funds for research and development activities. Some other factors that favour the growth of the global biomedical market include progress in genetic engineering and the fabrication of transgenic and humanized animal models that have a major impact on the precision of the preclinical studies.

For instance, in April of 2025, the FDA declared a plan that aimed to lower the necessity of animal testing in preclinical safety studies with a major focus on monoclonal antibody treatments. The concept is to facilitate the adoption of New Approach Methodologies (NAMs) such as computer modeling, organ-on-a-chip, and sophisticated in vitro assays.

Key Market Growth Drivers

Expansion of Drug Discovery and Preclinical Research

Pharmaceutical and biotechnology companies increasingly rely on animal models to evaluate drug candidates, understand pharmacological responses, and assess potential toxicity before clinical trials.

The expanding pipeline of novel therapeutics is supporting demand for specialized research models.

Rising Prevalence of Chronic Diseases

Increasing prevalence of cancer, cardiovascular diseases, neurological disorders, metabolic conditions, and infectious diseases is encouraging research into disease mechanisms and new therapeutic approaches.

Animal models play an important role in developing and validating experimental treatments.

Growing Adoption of Genetically Engineered Models

Advancements in genetic engineering are enabling researchers to develop models that more closely replicate specific human diseases.

Transgenic, knockout, knock-in, and humanized models are increasingly being used in advanced biomedical research.

Increasing Investments in Biotechnology and Life Sciences

Government agencies, pharmaceutical companies, biotechnology firms, and academic institutions are increasing investments in research infrastructure and innovative drug development technologies.

This is expanding the application base for animal models.

Analysis of Key Players

The animal model market is competitive, with leading companies focusing on genetically engineered models, specialized research animals, breeding services, and preclinical research solutions.

• Charles River Laboratories
• The Jackson Laboratory
• genOway
• Taconic Biosciences, Inc.
• Harbour BioMed.
• Janvier Labs
• Crown Bioscience
• Inotiv.
• Biocytogen Boston Corp
• Cyagen
• BioSpherix, LLC
• SelectScience
• Ingenious Targeting Laboratory.
• Ozgene Pty Ltd.
• Creative Animodel
• Other Prominent Players

Recent industry developments include expansion of genetically engineered model portfolios, development of humanized models, investments in preclinical research facilities, and increasing collaborations between model providers and pharmaceutical companies.

Key Player Strategies

Leading companies are implementing several strategic initiatives to strengthen market competitiveness:

• Development of genetically engineered animal models
• Expansion of humanized and disease-specific model portfolios
• Investment in advanced breeding and research infrastructure
• Strategic collaborations with pharmaceutical companies
• Expansion of preclinical research services
• Geographic expansion into emerging life sciences markets
• Development of customized animal models
• Investment in genomic and molecular characterization technologies
• Enhancement of animal welfare and research standards
• Expansion of contract research and model development capabilities

These strategies are helping companies address the growing demand for specialized models in drug discovery and biomedical research.

Market Challenges & Opportunities

Challenges

Despite strong growth prospects, the market faces challenges including ethical concerns regarding animal experimentation, increasingly stringent animal welfare regulations, high costs associated with specialized models, complex breeding requirements, and limitations in translating some animal research findings to humans.

Researchers and market participants must balance scientific requirements with evolving ethical and regulatory expectations.

Opportunities

Growing adoption of humanized models, genetically engineered animals, precision medicine, immuno-oncology research, rare disease studies, and personalized drug development presents significant opportunities.

Advancements in gene editing technologies, including CRISPR-based approaches, are enabling the development of increasingly sophisticated disease models.

The expansion of biotechnology research and growing demand for specialized preclinical testing will further support market growth.

Investment Landscape and ROI Outlook

The Animal Model Market continues to attract investments from pharmaceutical companies, biotechnology firms, contract research organizations, academic institutions, and specialized laboratory animal suppliers.

Investment is increasingly directed toward genetically engineered models, humanized models, advanced breeding facilities, genomic characterization, and preclinical research services.

As pharmaceutical R&D spending and demand for innovative preclinical models continue to increase, the market is expected to generate strong long-term commercial opportunities through 2035.

The combination of expanding drug pipelines, advances in genetic engineering, rising biomedical research investments, and increasing demand for disease-specific models positions the animal model market as an important segment within the global life sciences and preclinical research industry.

Market Segmentation

By Animal Type

• Mice
• Rat
• Guinea pigs
• Rabbits
• Hamsters
• Others

By Application

• Drug Discovery and Development
• Basic Research
• Others

By End-use

• Pharmaceutical & Biotechnology Companies
• Academic Research Institute
• Contract Research Organization E-commerce

Why Buy This Report?

• Gain comprehensive insights into current and future animal model market trends
• Access detailed market size estimates and forecasts through 2035
• Understand key growth drivers, challenges, and emerging opportunities
• Evaluate competitive positioning of leading animal model providers
• Analyze advancements in genetically engineered and humanized animal models
• Assess regional and segment-level market dynamics
• Identify high-growth investment opportunities across the preclinical research value chain
• Track recent collaborations, acquisitions, model launches, and technological developments
• Evaluate emerging applications in drug discovery, oncology, gene therapy, and precision medicine
• Support strategic business planning and investment decisions

Buy this Premium Research Report to gain valuable industry intelligence - https://www.transparencymarketresearch.com/checkout.php?rep_id=73248<ype=S

Frequently Asked Questions

·        How big was the global animal model market in 2024?

The global animal model market was valued at US$ 2.5 Bn in 2024

·        How big will the global animal model industry be in 2035?

The global animal model industry is projected to reach more than US$ 6.2 Bn by the end of 2035

·        What are the factors driving the animal model market?

Prevalence of chronic and complex diseases & advancements in genetic engineering are some of the factors driving the expansion of the animal model market.

·        What will be the CAGR of the global animal model industry during the forecast period?

The CAGR is anticipated to be 8.6% from 2025 to 2035

·        Which region will account for a major share of the animal model sector during the forecast period?

North America is expected to account for the largest share from 2025 to 2035

Explore Latest Research Reports by Transparency Market Research:

Flow Cytometry Market

Bone Marrow Aspirate Concentrates Market

Microplate Reader Market

Next Generation Sequencers (NGS) Market

Antimicrobial Ingredients Market

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com  

Sales Inquiries: sales@transparencymarketresearch.com  

Media Inquiries: media@transparencymarketresearch.com